We are live on ! Find out more
ACM

Ayer Capital Management Portfolio holdings

AUM $26.8M
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.9M
AUM Growth
Cap. Flow
+$16.6M
Cap. Flow %
98.26%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELGZ
1
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$12.9M 76.53%
+1,747,375
New +$12.7M
ARTC
2
DELISTED
ARTHROCARE CORP
ARTC
$3.97M 23.47%
+115,009
New +$3.96M

Similar funds

Ayer Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Ayer Capital Management, which disclosed 2 positions worth $16.9M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Celgene Corporation Contingent Value Rights: 1,747,375 shares worth $12.9M.

  • Ayer Capital Management's largest Q2 2013 buy was Celgene Corporation Contingent Value Rights: 1,747,375 shares worth $12.9M.
  • Ayer Capital Management's ten largest holdings make up 100% of its $16.9M portfolio in Q2 2013.
  • Ayer Capital Management disclosed 2 positions in Q2 2013, its first 13F filing on record.

Based on Ayer Capital Management's 13F filing for Q2 2013, filed 16 Aug 2013.